YungShin Global Holding Corporation (TPE:3705)

Market Cap	16.51B
Revenue (ttm)	8.41B
Net Income (ttm)	1.23B
Shares Out	266.36M
EPS (ttm)	4.62
PE Ratio	13.42
Forward PE	n/a
Dividend	2.30 (3.69%)
Ex-Dividend Date	Jun 24, 2025

Volume	2,847,741
Average Volume	4,047,640
Open	62.20
Previous Close	62.40
Day's Range	61.80 - 62.70
52-Week Range	48.90 - 69.90
Beta	0.10
RSI	45.07
Earnings Date	Aug 8, 2025

About YungShin Global Holding

YungShin Global Holding Corporation, through its subsidiaries, invests in, manufactures, and sells medicines, animal drugs, agricultural chemicals, industrial medicines, and cosmetics. The company is also involved in trade, investment, and other related businesses; import and export trading; and sale of medicine. It has operations in Taiwan, the United States, Mainland China, and Japan. The company was incorporated in 2011 and is headquartered in Taipei City, Taiwan.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2011
• Country: Taiwan
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 3705

Financial Performance

In 2024, YungShin Global Holding's revenue was 8.03 billion, an increase of 14.29% compared to the previous year's 7.03 billion. Earnings were 1.17 billion, an increase of 41.24%.